1-5 of 5
Authors: Hans Verkerke
Sort by
Journal Article
Diagnostic Utility of SARS-CoV-2 Nucleocapsid Antigenemia: A Meta-analysis Open Access
Gregory L Damhorst and others
Open Forum Infectious Diseases, Volume 11, Issue 10, October 2024, ofae561, https://doi.org/10.1093/ofid/ofae561
Published: 02 October 2024
Journal Article
639. Are SARS-CoV-2 antigenemia measurements still relevant? Comparison of Omicron era to early pandemic plasma nucleocapsid levels Open Access
Gregory L Damhorst and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.703, https://doi.org/10.1093/ofid/ofad500.703
Published: 27 November 2023
Journal Article
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection Open Access
Gregory L Damhorst and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad226, https://doi.org/10.1093/ofid/ofad226
Published: 02 May 2023
Journal Article
Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19 Open Access
Eli Wilber and others
Open Forum Infectious Diseases, Volume 9, Issue 8, August 2022, ofac419, https://doi.org/10.1093/ofid/ofac419
Published: 17 August 2022
Journal Article
371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021 Open Access
Daniel Graciaa and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S287–S288, https://doi.org/10.1093/ofid/ofab466.572
Published: 04 December 2021
Advertisement
Advertisement